AM Wardley

FULVESTRANT: A REVIEW OF ITS DEVELOPMENT, PRE‐CLINICAL AND CLINICAL DATA

AM Wardley, 2002, International journal of clinical practice.

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

A. Howell, W. Ryder, P. Wilkinson, 2004, British Journal of Cancer.

tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation

H. Earl, A. Wardley, C. Poole, 2008, British Journal of Cancer.

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

A. Wardley, P. Barrett-Lee, P. Canney, 2009, British Journal of Cancer.

The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone.

G. Jayson, A. Wardley, D. Goldsmith, 1998, British Journal of Cancer.